DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Abratt RP, Brune D, Dimopoulos MA. et al.
Randomised phase III study of intravenous vinorelbine plus hormone therapy versus hormone therapy alone in hormone-refractory prostate cancer.
Ann Oncol 2004; 27: 1613-1621
We do not assume any responsibility for the contents of the web pages of other providers.